| Association between interleukin-12 p40 subunit and risk of primary Sjögren’s syndrome: a Mendelian randomization study BP Zuckerman, Z Yang, A Warwick, C Wincup, M Russell, JB Galloway, ... Rheumatology, keae475, 2024 | | 2024 |
| The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19 K Bechman, ACA Green, MD Russell, Z Yang, B Zheng, S Norton, ... Journal of Infection 89 (3), 106227, 2024 | | 2024 |
| Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares MD Russell, L Ameyaw-Kyeremeh, F Dell’Accio, H Lapham, N Head, ... Rheumatology 63 (8), 2222-2229, 2024 | | 2024 |
| Predictors of biologic and targeted synthetic DMARD initiation for rheumatoid arthritis across underserved patient groups: insights from a national cohort study MD Russell, M Gibson, B Zuckerman, K Kumar, S Dubey, MA Adas, ... The Lancet Rheumatology, 2024 | | 2024 |
| Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit K Bechman, ES Cook, E Alveyn, A Houssien, M Stevens, MD Russell, ... Rheumatology 63 (7), 1856-1867, 2024 | | 2024 |
| Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study D Nagra, K Bechman, MD Russell, Z Yang, MA Adas, HK Molabanti, ... Rheumatology, keae305, 2024 | | 2024 |
| AB1343 NO WANING OF PNEUMOCOCCAL VACCINE RESPONSES OVER TIME IN PEOPLE WITH INFLAMMATORY ARTHRITIS: FINDINGS FROM A SINGLE CENTRE COHORT K Bechman, D Nagra, C Baldwin, MA Adas, M Russell, I Karafotias, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 2023-2023, 2024 | | 2024 |
| POS0709 THE RISK OF SERIOUS INFECTIONS IN PATIENTS WITH EARLY INFLAMMATORY ARTHRITIS: RESULTS FROM A LARGE UK COHORT (NEIAA) MA Adas, K Bechman, B Zuckerman, M Russell, S Patel, D Nagra, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 607-608, 2024 | | 2024 |
| POS0903 ABATACEPT AND THE RISK OF MALIGNANCY: A META-ANALYSIS ACROSS DISEASE INDICATIONS B Zuckerman, M Gibson, R Roy, M Hughes, D Mehta, MA Adas, K Ng, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1142-1143, 2024 | | 2024 |
| POS0934 VALIDATION OF THE GIANT CELL ARTERITIS PROBABILITY SCORE AT A LARGE TERTIARY CENTRE Z Yang, K Bechman, D Nagra, B Zuckerman, M Russell, E Alveyn, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1100-1101, 2024 | | 2024 |
| POS0867 INFLIXIMAB THERAPY FOR MULTISYSTEM SARCOIDOSIS: A SINGLE CENTRE EXPERIENCE D Nagra, K Bechman, S Bukhari, C Baldwin, E Alveyn, MA Adas, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 854-854, 2024 | | 2024 |
| POS1112 TRENDS IN NATIONAL HOSPITALISATIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS, IDIOPATHIC INFLAMMATORY MYOPATHIES AND SYSTEMIC SCLEROSIS OVER THE LAST 25 YEARS IN ENGLAND M Ong, M Russell, J Galloway, C Wincup Annals of the Rheumatic Diseases 83 (Suppl 1), 963-963, 2024 | | 2024 |
| AB0204 RETROSPECTIVE ANALYSIS OF JAK INHIBITORS AT A LARGE TERTIARY CENTRE IN UK Z Yang, K Bechman, D Nagra, B Zuckerman, MA Adas, M Russell, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1339-1340, 2024 | | 2024 |
| Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta‐Analysis K Bechman, Z Yang, M Adas, D Nagra, A S. Uğuzlar, MD Russell, ... Arthritis & Rheumatology 76 (5), 704-714, 2024 | 1 | 2024 |
| OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate AD Brown, L Fisher, HJ Curtis, M Wiedemann, WJ Hulme, V Speed, ... British Journal of Clinical Pharmacology, 2024 | 1 | 2024 |
| P086 Trends in the Incidence and Management of Gout in England: A Nationwide Study using the OpenSAFELY Platform MD Russell, J Massey, E Roddy, B MacKenna, S Bacon, B Goldacre, ... Rheumatology 63 (Supplement_1), keae163. 127, 2024 | | 2024 |
| OA06 Regional differences in work productivity in patients with early rheumatoid arthritis in England and Wales E Alveyn, M Adas, I Sahbudin, A Boonen, K Bechman, MD Russell, ... Rheumatology 63 (Supplement_1), keae163. 006, 2024 | | 2024 |
| OA20 Serious infections hospital admissions and mortality in patients with early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit M Adas, K Bechman, M Russell, I Karafotias, D Nagra, S Patel, ... Rheumatology 63 (Supplement_1), keae163. 020, 2024 | | 2024 |
| P039 A systematic review and meta analysis of anti rheumatic drugs and pneumococcal vaccine immunogenicity in inflammatory arthritis D Nagra, K Bechman, M Adas, Z Yang, E Alveyn, S Patel, M Russell, ... Rheumatology 63 (Supplement_1), keae163. 081, 2024 | | 2024 |
| OA39 The influence of safety warnings on the prescribing of JAK inhibitors in England: an interrupted time-series analysis MD Russell, Z Yang, B Walter, E Alveyn, K Bechman, A Miracle, D Nagra, ... Rheumatology 63 (Supplement_1), keae163. 039, 2024 | | 2024 |
